Vena cava filters

Too often, too many, or just right

Vishesh Kumar, David P. Slovut

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Venous thromboembolism (VTE) comprising both deep vein thrombosis (DVT) and pulmonary embolism (PE) is a common disease in the general population. The mainstay of the treatment for the most patients is anticoagulation. However, for patients who fail anticoagulation or are unable to receive anticoagulation because of a contraindication or increased risk of bleeding, inferior vena cava filters (IVCF) offer an attractive alternative for prevention of PE. Although beneficial in some patients, the utilization of IVCF has skyrocketed despite limited level I evidence. Much of this increase occurred after the introduction of optional (or retrievable) IVCF. Owing to low retrieval rates, so-called optional filters frequently become permanent, which may add to the morbidity associated with their routine use. In this review, we discuss various types of filters, their main indications, evidence behind their use, and the patterns of utilization.

Original languageEnglish (US)
Pages (from-to)114-125
Number of pages12
JournalVascular Disease Management
Volume11
Issue number5
StatePublished - 2014

Fingerprint

Vena Cava Filters
Pulmonary Embolism
Venous Thromboembolism
Venous Thrombosis
Hemorrhage
Morbidity
Population
Therapeutics

Keywords

  • Inferior vena cava
  • morbidity

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Vena cava filters : Too often, too many, or just right. / Kumar, Vishesh; Slovut, David P.

In: Vascular Disease Management, Vol. 11, No. 5, 2014, p. 114-125.

Research output: Contribution to journalArticle

@article{476a73aaa6e54b41b1c8fefc1f18d34c,
title = "Vena cava filters: Too often, too many, or just right",
abstract = "Venous thromboembolism (VTE) comprising both deep vein thrombosis (DVT) and pulmonary embolism (PE) is a common disease in the general population. The mainstay of the treatment for the most patients is anticoagulation. However, for patients who fail anticoagulation or are unable to receive anticoagulation because of a contraindication or increased risk of bleeding, inferior vena cava filters (IVCF) offer an attractive alternative for prevention of PE. Although beneficial in some patients, the utilization of IVCF has skyrocketed despite limited level I evidence. Much of this increase occurred after the introduction of optional (or retrievable) IVCF. Owing to low retrieval rates, so-called optional filters frequently become permanent, which may add to the morbidity associated with their routine use. In this review, we discuss various types of filters, their main indications, evidence behind their use, and the patterns of utilization.",
keywords = "Inferior vena cava, morbidity",
author = "Vishesh Kumar and Slovut, {David P.}",
year = "2014",
language = "English (US)",
volume = "11",
pages = "114--125",
journal = "Vascular Disease Management",
issn = "1553-8036",
publisher = "HMP Communications",
number = "5",

}

TY - JOUR

T1 - Vena cava filters

T2 - Too often, too many, or just right

AU - Kumar, Vishesh

AU - Slovut, David P.

PY - 2014

Y1 - 2014

N2 - Venous thromboembolism (VTE) comprising both deep vein thrombosis (DVT) and pulmonary embolism (PE) is a common disease in the general population. The mainstay of the treatment for the most patients is anticoagulation. However, for patients who fail anticoagulation or are unable to receive anticoagulation because of a contraindication or increased risk of bleeding, inferior vena cava filters (IVCF) offer an attractive alternative for prevention of PE. Although beneficial in some patients, the utilization of IVCF has skyrocketed despite limited level I evidence. Much of this increase occurred after the introduction of optional (or retrievable) IVCF. Owing to low retrieval rates, so-called optional filters frequently become permanent, which may add to the morbidity associated with their routine use. In this review, we discuss various types of filters, their main indications, evidence behind their use, and the patterns of utilization.

AB - Venous thromboembolism (VTE) comprising both deep vein thrombosis (DVT) and pulmonary embolism (PE) is a common disease in the general population. The mainstay of the treatment for the most patients is anticoagulation. However, for patients who fail anticoagulation or are unable to receive anticoagulation because of a contraindication or increased risk of bleeding, inferior vena cava filters (IVCF) offer an attractive alternative for prevention of PE. Although beneficial in some patients, the utilization of IVCF has skyrocketed despite limited level I evidence. Much of this increase occurred after the introduction of optional (or retrievable) IVCF. Owing to low retrieval rates, so-called optional filters frequently become permanent, which may add to the morbidity associated with their routine use. In this review, we discuss various types of filters, their main indications, evidence behind their use, and the patterns of utilization.

KW - Inferior vena cava

KW - morbidity

UR - http://www.scopus.com/inward/record.url?scp=84900008982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900008982&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 114

EP - 125

JO - Vascular Disease Management

JF - Vascular Disease Management

SN - 1553-8036

IS - 5

ER -